| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 3 | -284,263 | 100% | $7.59 | -$2,158,199 |
| Net | -3 | -284,263 | -100% | -$2,158,199 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jon P. Stonehouse | Director | $11,962,064 | 27 Feb 2026 | ||
| Charles K. Gayer | President and CCO | $5,248,732 | 19 Dec 2025 | ||
| Alane P. Barnes | Chief Legal Officer | $3,050,445 | -$1,493,787 | -33% | 19 Dec 2025 |
| Helen M. Thackray | Chief R&D Officer | $2,829,885 | 31 Mar 2025 | ||
| Anthony Doyle | Chief Financial Officer | $2,792,437 | 19 Dec 2024 | ||
| Ronald Dullinger | Chief Commercial Officer | $2,015,146 | 01 Jan 2026 | ||
| Babar Ghias | Chief Financial Officer | $1,862,091 | 17 Dec 2025 | ||
| Yarlagadda S. Babu | Chief Discovery Officer | $1,806,173 | 14 Nov 2022 | ||
| Nancy J. Hutson | Director | $1,025,086 | 12 Jun 2025 | ||
| VINCENT MILANO | Director | $805,586 | 27 Feb 2026 | ||
| Steven K. Galson | Director | $732,805 | 12 Jun 2025 | ||
| ALAN G. LEVIN | Director | $664,562 | 12 Jun 2025 | ||
| ROBERT ALEXANDER INGRAM | Director | $606,198 | 28 Feb 2023 | ||
| THERESA HEGGIE | Director | $556,302 | -$595,868 | -52% | 13 Aug 2025 |
| STEVE ASELAGE | Director | $469,377 | 12 Jun 2024 | ||
| KENNETH B. LEE JR | Director | $416,621 | 13 Jun 2023 | ||
| Amy E. McKee | Director | $371,280 | 27 Feb 2026 | ||
| GEORGE B. ABERCROMBIE | Director | $235,344 | 12 Jun 2024 | ||
| William P. Sheridan | Chief Medical Officer | $229,622 | 10 Mar 2022 | ||
| MACHELLE SANDERS | Director | $218,783 | -$68,544 | -24% | 13 Nov 2025 |
| Steven Frank | Director | $165,401 | 27 Feb 2026 | ||
| Jill C. Milne | Director | $134,592 | 27 Feb 2026 | ||
| Michael L. Jones | Exec. Director, Finance - PAO | $100,751 | 19 Dec 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|